Chronic Obstructive Pulmonary Disease Market 2025 To Reach $34.30 billion By 2034 At Rate Of 4.4%

Chronic Obstructive Pulmonary Disease Market

According to the latest research by Polaris Market Research, the global chronic obstructive pulmonary disease market was valued at USD 22.32 billion in 2024. It is expected to reach USD 34.30 billion by 2034, with a CAGR of 4.4% during the forecast period of 2025-2034.

Market Scope

Chronic obstructive pulmonary disease (COPD) is a lung condition developed by injury to the lungs. This injury causes swelling and exasperation, also known as inflammation, within the airways, which restricts the airflow into and out of the lungs. This airflow limitation is known as obstruction. Indications involve issues of breathing, everyday cough that fosters mucus, and a compact whistling sound in the lungs known as wheezing.

Pulmonary function examinations are used to detect how well the lungs are functioning. Spirometry is a test in which one exhales forcibly through a tube linked to a machine. The machine measures the quantity of air the lungs can carry and how swiftly the air goes back and forth from the lungs. Another test is the lung volume test, which measures the amount of air the lung holds at varied times when inhaling and exhaling.

Request For a Sample with An Exclusive Look at the Latest Trends and Upcoming Advancements:
https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market/request-for-sample

Market Drivers

Growing Existence of COPD: The growing existence of pulmonary illnesses, especially COPD, is driving the market. As per the World Health Organization (WHO), COPD is the third most significant cause of death globally, bringing about 3.23 million deaths in 2019. The same report points out that approximately 90% of COPD deaths in those under 70 years of age take place in low and middle-income nations, pushing the chronic obstructive pulmonary disease market ahead.

Global Surge in Elderly Population: The worldwide surge in the aging population causes market growth. Older adults are more vulnerable to experiencing COPD because of age-connected physiological alterations and extended subjection to probability elements. The United Nations communicates that the aggregate of persons aged 65 years and above are expected to magnify from 727 million in 2020 to 1.5 billion in 2050. This demographic move is anticipated to cause higher cases of COPD, thus escalating the demand for therapeutic medications.

Need More Information? Inquire more about this report before purchase:
https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market/inquire-before-buying

Key Players

Prominent market contenders are spending excessively on R&D to improve their offerings, which will help the market to grow even more. Some of the companies which are currently dominating the market are:

• Abbott Laboratories
• Almirall S.A.
• AstraZeneca plc
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• Circassia Pharmaceuticals plc
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Mylan N.V. (now part of Viatris Inc.)
• Novartis International AG
• Pfizer Inc.
• Sunovion Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.

Regional Insights

North America holds a substantial chronic obstructive pulmonary disease market share due to its progressive healthcare framework and the existence of leading pharmaceutical firms.
In Europe, the market is driven by the growing existence of the illness, especially in nations such as Germany, France, and the UK.

Browse Full Report:
https://www.polarismarketresearch.com/industry-analysis/global-chronic-obstructive-pulmonary-disease-market

Segmental Outlook

Polaris Market Research has segmented the Chronic Obstructive Pulmonary Disease market report on the basis of drug type, product type, and end users:

By Drug Type Outlook
• Phosphodiesterase-4 Inhibitors
• Bronchodilators
• Methylxanthines
• Corticosteroids

By Product Type Outlook
• Inhalers
• Nebulizers

By End Users Outlook
• Hospitals & Clinics
• Homecare Settings
• Others

Top Trending Reports of Polaris Market Research:

Mining Lubricants Market
https://www.polarismarketresearch.com/industry-analysis/mining-lubricants-market
Peritoneal Dialysis Market
https://www.polarismarketresearch.com/industry-analysis/peritoneal-dialysis-market
High-Performance Polyamides Market
https://www.polarismarketresearch.com/industry-analysis/high-performance-polyamides-market
Biopolymer Packaging Market
https://www.polarismarketresearch.com/industry-analysis/biopolymer-packaging-market
Asset Tokenization Market
https://www.polarismarketresearch.com/industry-analysis/asset-tokenization-market

Contact:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.